These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 19061437)

  • 1. PPARs and the cardiovascular system.
    Hamblin M; Chang L; Fan Y; Zhang J; Chen YE
    Antioxid Redox Signal; 2009 Jun; 11(6):1415-52. PubMed ID: 19061437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.
    Krönke G; Kadl A; Ikonomu E; Blüml S; Fürnkranz A; Sarembock IJ; Bochkov VN; Exner M; Binder BR; Leitinger N
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1276-82. PubMed ID: 17413033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARs as therapeutic targets in cardiovascular disease.
    van Bilsen M; van Nieuwenhoven FA
    Expert Opin Ther Targets; 2010 Oct; 14(10):1029-45. PubMed ID: 20854178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
    Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases.
    Monsalve FA; Pyarasani RD; Delgado-Lopez F; Moore-Carrasco R
    Mediators Inflamm; 2013; 2013():549627. PubMed ID: 23781121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease.
    Wagner N; Wagner KD
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PPAR in cardiovascular diseases.
    Das SK; Chakrabarti R
    Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):193-209. PubMed ID: 18221086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
    J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis].
    Knapp P; Jarzabek K; Błachnio A; Zbroch T
    Ginekol Pol; 2006 Aug; 77(8):643-51. PubMed ID: 17076197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease.
    Robinson E; Grieve DJ
    Pharmacol Ther; 2009 Jun; 122(3):246-63. PubMed ID: 19318113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARs: the vasculature, inflammation and hypertension.
    Duan SZ; Usher MG; Mortensen RM
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):128-33. PubMed ID: 19434050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic PPARs: their role in liver physiology, fibrosis and treatment.
    Zardi EM; Navarini L; Sambataro G; Piccinni P; Sambataro FM; Spina C; Dobrina A
    Curr Med Chem; 2013; 20(27):3370-96. PubMed ID: 23746272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PPARδ signaling in the cardiovascular system.
    Ding Y; Yang KD; Yang Q
    Prog Mol Biol Transl Sci; 2014; 121():451-73. PubMed ID: 24373246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of PPAR activity via phosphorylation.
    Burns KA; Vanden Heuvel JP
    Biochim Biophys Acta; 2007 Aug; 1771(8):952-60. PubMed ID: 17560826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of PPARs: from molecular characterization to physiological relevance.
    Diradourian C; Girard J; Pégorier JP
    Biochimie; 2005 Jan; 87(1):33-8. PubMed ID: 15733734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.